[Five-drug therapy in addition to hormonal treatment in advance breast cancer metastatic to the lung (author's transl)].
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D012075:Remission, Spontaneous; D012189:Retrospective Studies; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D012739:Gonadal Steroid Hormones; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Kombinierte intermittierende zytostatische Therapie in Verbindung mit Hormonbehandlung beim intrathorakal metastasierten Mammakarzinom